News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ParagonDx Opens Clinical Diagnostic Laboratory: Launches with Genetic Test for Warfarin Patients



1/8/2009 9:45:49 AM

MORRISVILLE, N.C.--(BUSINESS WIRE)--ParagonDx LLC, a leader in genetic testing diagnostics, is now offering genetic testing for warfarin sensitivity to local doctors and patients. The test helps doctors prevent excessive bleeding in those patients who are taking warfarin (Coumadin©), a common anti-coagulant prescribed to prevent and treat blood clots. By using this test, doctors can understand the genetic component that can help achieve the optimal level of warfarin. This kind of testing has been shown to lower the risk of potential life-threatening adverse drug reactions.

Read at BioSpace.com


comments powered by Disqus
ParagonDx
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES